Company Filing History:
Years Active: 2021
Title: Tucker Read Ezell: Innovator in Drug Responsive Domains
Introduction
Tucker Read Ezell is an accomplished inventor based in Acton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of drug responsive domains.
Latest Patents
Ezell holds a patent for "CA2 compositions and methods for tunable regulation." This patent provides drug responsive domains derived from human carbonic anhydrase 2 that can modulate protein stability for human interleukin 15 (IL15) payloads. The compositions and methods outlined in this patent have the potential to advance therapeutic applications.
Career Highlights
Ezell is currently employed at Obsidian Therapeutics, Inc., where he continues to innovate in the realm of biotechnology. His work focuses on enhancing the efficacy of therapeutic agents through advanced protein engineering techniques.
Collaborations
Ezell collaborates with talented individuals such as Kutlu Goksu Elpek and Dhruv Kam Sethi, contributing to a dynamic research environment that fosters innovation.
Conclusion
Tucker Read Ezell is a notable inventor whose work in drug responsive domains is paving the way for advancements in therapeutic applications. His contributions to biotechnology are significant and continue to impact the field positively.